Effectiveness and Safety of Adding Bevacizumab to First Line Chemotherapy in Lung Cancer Patients With Stable Disease
Clinical trial NCT03240549 · UNKNOWN
Trial details
- NCT number
- NCT03240549
- Sponsor
- Beijing Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-01
- Primary completion
- 2018-08-31
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.